Date published: 
31 July 2020
Intended audience: 
General public
Person receiving vaccination

Vaccine manufacturers seeking listing on the National Immunisation Program (NIP) Schedule must ask for advice from the Australian Technical Advisory Group on Immunisation (ATAGI) before making a submission to the Pharmaceutical Benefits Advisory Committee (PBAC).

A new process for requesting this advice is now in effect.  

Vaccine manufacturers can contact the ATAGI secretariat with any questions about these arrangements.